Product
Oridonin
1 clinical trial
3 indications
Indication
NLRP3Indication
hs-CRPIndication
AngioplastyClinical trial
Effect of Inflammasome Inhibitor on High-sensitivity C-reactive Protein in Patients After Percutaneous Coronary InterventionStatus: Completed, Estimated PCD: 2023-02-01